Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-01-12T09:18:08.299Z Has data issue: false hasContentIssue false
  • English
  • Français

Cognitive–behavioural therapy augments the effects of deep brain stimulation in obsessive–compulsive disorder

Published online by Cambridge University Press:  25 April 2014

M. Mantione ,
D. H. Nieman ,
M. Figee  and
D. Denys
M. Mantione*
Affiliation:
Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
D. H. Nieman
Affiliation:
Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
M. Figee
Affiliation:
Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
D. Denys*
Affiliation:
Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands The Netherlands Institute for Neuroscience, an Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam, The Netherlands
*
* Address for correspondence: Mrs M. Mantione, Academic Medical Center, University of Amsterdam, PA.0-162, PO Box 22660, 1100 DD Amsterdam, The Netherlands. (Email: m.h.mantione@amc.nl) [M.M.] (Email: ddenys@gmail.com) [D.D.]
* Address for correspondence: Mrs M. Mantione, Academic Medical Center, University of Amsterdam, PA.0-162, PO Box 22660, 1100 DD Amsterdam, The Netherlands. (Email: m.h.mantione@amc.nl) [M.M.] (Email: ddenys@gmail.com) [D.D.]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background.

Deep brain stimulation (DBS) is a promising new treatment for patients with treatment-refractory obsessive–compulsive disorder (OCD). However, since most DBS patients only show a partial response, the treatment still needs to be improved. In this study we hypothesized that cognitive–behavioural therapy (CBT) could optimize the post-operative management in DBS and we evaluated the efficacy of CBT as augmentation to DBS targeted at the nucleus accumbens.

Method.

A total of 16 patients with treatment-refractory OCD were treated with DBS targeted at the nucleus accumbens. After stabilization of decline in OCD symptoms, a standardized 24-week CBT treatment programme was added to DBS in an open-phase trial of 8 months. Changes in obsessive–compulsive, anxiety and depressive symptoms were evaluated using the Yale–Brown Obsessive Compulsive Scale, Hamilton Anxiety Scale and Hamilton Rating Scale for Depression.

Results.

Following the addition of CBT to DBS, a significant decrease in obsessive–compulsive symptoms was observed, but not in anxiety and depressive symptoms. In a subsequent double-blind phase, in which stimulation was discontinued, OCD symptoms returned to baseline (relapse) and anxiety and depressive symptoms worsened (rebound) compared with baseline.

Conclusions.

The results of this explorative study suggest that a combined treatment of accumbens DBS and CBT may be optimal for improving obsessive–compulsive symptoms in treatment-refractory OCD. However, a subsequent randomized controlled trial is necessary to draw firm conclusions. It seems that DBS results in affective changes that may be required to enable response prevention in CBT. This may indicate that DBS and CBT act as two complementary treatments.

Keywords

Compulsivitycognitive behavioural therapydeep brain stimulationexposure and response preventionobsessive-compulsive disorder
Type
Original Articles
Information
Psychological Medicine , Volume 44 , Issue 16 , December 2014 , pp. 3515 - 3522
Copyright
Copyright © Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abelson, JL, Curtis, GC, Sagher, O, Albucher, RC, Harrigan, M, Taylor, SF, Martis, B, Giordani, B (2005). Deep brain stimulation for refractory obsessive–compulsive disorder. Biological Psychiatry 57, 510–516.CrossRefGoogle ScholarPubMed
Abramowitz, JS (2006). The psychological treatment of obsessive–compulsive disorder. Canadian Journal of Psychiatry 51, 407–416.Google Scholar
Bewernick, BH, Hurlemann, R, Matusch, A, Kayser, S, Grubert, C, Hadrysiewicz, B, Axmacher, N, Lemke, M, Cooper-Mahkorn, D, Cohen, MX, Brockmann, H, Lenartz, D, Sturm, V, Schlaepfer, TE (2010). Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biological Psychiatry 67, 110–116.CrossRefGoogle ScholarPubMed
Brody, AL, Saxena, S, Schwartz, JM, Stoessel, PW, Maidment, K, Phelps, ME, Baxter, LR Jr (1998). FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive–compulsive disorder. Psychiatry Research 84, 1–6.Google Scholar
Craske, MG, Kircanskin, K, Zelikowsky, M, Mystkowski, J, Chowdhury, N, Baker, A (2008). Optimizing inhibitory learning during exposure therapy. Behaviour Research and Therapy 46, 5–27.CrossRefGoogle ScholarPubMed
De Koning, PP, Figee, M, van den Munckhof, P, Schuurman, PR, Denys, D (2011). Current status of deep brain stimulation for obsessive–compulsive disorder: a clinical review of different targets. Current Psychiatry Reports 13, 274–282.Google Scholar
Denys, D (2006). Pharmacotherapy of obsessive–compulsive disorder and obsessive–compulsive spectrum disorders. Psychiatric Clinics of North America 29, 553–584.Google Scholar
Denys, D, Mantione, M, Figee, M, van den Munckhof, P, Koerselman, F, Westenberg, H, Bosch, A, Schuurman, R (2010). Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive–compulsive disorder. Archives of General Psychiatry 67, 1061–1068.Google Scholar
Eddy, KT, Dutra, L, Bradley, R, Westen, DA (2004). A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive–compulsive disorder. Clinical Psychology Review 24, 1011–1030.CrossRefGoogle ScholarPubMed
Figee, M, Luigjes, J, Smolders, R, Valencia-Alfonso, CE, van Wingen, G, de Kwaasteniet, B, Mantione, M, Ooms, P, de Koning, P, Vulink, N, Levar, N, Droge, L, van den Munckhof, P, Schuurman, PR, Nederveen, A, van den Brink, W, Mazaheri, A, Vink, M, Denys, D (2013). Deep brain stimulation restores frontostriatal network activity in obsessive–compulsive disorder. Nature Neuroscience 16, 386–387.Google Scholar
Figee, M, Mantione, M, van den Munckhof, P, Schuurman, PR, Denys, D (2010). Targets for deep brain stimulation in obsessive–compulsive disorder. Psychiatric Annals 40, 492–498.Google Scholar
Foa, EB, Liebowitz, MR, Kozak, MJ, Davies, S, Campeas, R, Franklin, ME, Huppert, JD, Kjernisted, K, Rowan, V, Schmidt, AB, Simpson, HB, Tu, X (2005). Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive–compulsive disorder. American Journal of Psychiatry 162, 151–161.Google Scholar
Franklin, M, Abramowitz, J, Foa, E, Kozak, M, Levitt, J (2000). Effectiveness of exposure and ritual prevention for obsessive–compulsive disorder: randomized compared with nonrandomized samples. Journal of Consulting and Clinical Psychology 68, 594–602.Google Scholar
Freyer, T, Klöppel, S, Tüscher, O, Kordon, A, Zurowski, B, Kuelz, AK, Speck, O, Glauche, V, Voderholzer, U (2011). Frontostriatal activation in patients with obsessive–compulsive disorder before and after cognitive behavioral therapy. Psychological Medicine 41, 207–216.Google Scholar
Gillan, CM, Morein-Zamir, S, Urcelay, GP, Sule, A, Voon, V, Apergis-Schoute, AM, Fineberg, NA, Sahakian, BJ, Robbins, TW (2014). Enhanced avoidance habits in obsessive–compulsive disorder. Biological Psychiatry 75, 631–638.Google Scholar
Goodman, WK, Foote, KD, Greenberg, BD, Ricciuti, N, Bauer, R, Ward, H, Shapira, NA, Wu, SS, Hill, CL, Rasmussen, SA, Okun, MS (2010). Deep brain stimulation for intractable obsessive compulsive disorder: pilot study using a blinded, staggered-onset design. Biological Psychiatry 67, 535–542.CrossRefGoogle ScholarPubMed
Goodman, WK, Price, LH, Rasmussen, SA, Mazure, C, Delgado, P, Heninger, GR, Charney, DS (1989 a). The Yale-Brown Obsessive Compulsive Scale. II. Validity. Archives of General Psychiatry 46, 1012–1016.CrossRefGoogle ScholarPubMed
Goodman, WK, Price, LH, Rasmussen, SA, Mazure, C, Fleischmann, RL, Hill, CL, Heninger, GR, Charney, DS (1989 b). The Yale-Brown Obsessive Compulsive Scale. I. Development, use and reliability. Archives of General Psychiatry 46, 1006–1011.Google Scholar
Hamilton, M (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology 32, 50–55.Google Scholar
Hamilton, M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 23, 56–62.CrossRefGoogle ScholarPubMed
Huff, W, Lenartz, D, Schormann, M, Lee, SH, Kuhn, J, Koulousakis, A, Mai, J, Daumann, J, Maarouf, M, Klosterkötter, J, Sturm, V (2010). Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive–compulsive disorder: outcomes after one year. Clinical Neurology and Neurosurgery 112, 137–143.Google Scholar
Kozak, MJ, Foa, EB (1997). Mastery of Obsessive Compulsive Disorder: A Cognitive Behavioural Approach. Psychological Corp.: San Antonio.Google Scholar
Mallet, L, Polosan, M, Jaafari, N, Baup, N, Welter, ML, Fontaine, D, du Montcel, ST, Yelnik, J, Chéreau, I, Arbus, C, Raoul, S, Aouizerate, B, Damier, P, Chabardès, S, Czernecki, V, Ardouin, C, Krebs, MO, Bardinet, E, Chaynes, P, Burbaud, P, Cornu, P, Derost, P, Bougerol, T, Bataille, B, Mattei, V, Dormont, D, Devaux, B, Vérin, M, Houeto, JL, Pollak, P, Benabid, AL, Agid, Y, Krack, P, Millet, B, Pelissolo, A; STOC Study Group (2008). Subthalamic nucleus stimulation in severe obsessive–compulsive disorder. New England Journal of Medicine 359, 2121–2134.CrossRefGoogle ScholarPubMed
March, JS, Frances, A, Kahn, DA, Carpenter, D (1997). The expert consensus guideline series: treatment of obsessive–compulsive disorder. Journal of Clinical Psychiatry 58 (Suppl. 4), 5–71.Google Scholar
Nakao, T, Nakagawa, A, Yoshiura, T, Nakatani, E, Nabeyama, M, Yoshizato, C, Kudoh, A, Tada, K, Yoshioka, K, Kawamoto, M, Togao, O, Kanba, S (2005). Brain activation of patients with obsessive–compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study. Biological Psychiatry 57, 901–910.CrossRefGoogle ScholarPubMed
Nuttin, BJ, Gabriëls, LA, Cosyns, PR, Meyerson, BA, Andréewitch, S, Sunaert, SG, Maes, AF, Dupont, PJ, Gybels, JM, Gielen, F, Demeulemeester, HG (2003). Long-term electrical capsular stimulation in patients with obsessive–compulsive disorder. Neurosurgery 52, 1263–1272.CrossRefGoogle ScholarPubMed
O'Connor, KP, Aardema, F, Robillard, S, Guay, S, Pélissier, MC, Todorov, C, Borgeat, F, Leblanc, V, Grenier, S, Doucet, P (2006). Cognitive behaviour therapy and medication in the treatment of obsessive–compulsive disorder. Acta Psychiatrica Scandinavia 113, 408–419.Google Scholar
Pence, SL, Sulkowski, ML, Jordan, C, Storch, EA (2010). When exposures go wrong: trouble-shooting guidelines for managing difficult scenarios that arise in exposure-based treatment for obsessive–compulsive disorder. American Journal of Psychotherapy 64, 39–53.CrossRefGoogle Scholar
Rodriguez-Romaguera, J, Do Monte, FH, Quirk, GJ (2012). Deep brain stimulation of the ventral striatum enhances extinction of conditioned fear. Proceedings of the National Academy of Sciences USA 109, 8764–8769.Google Scholar
Simpson, HB, Foa, EB, Liebowitz, MR, Ledley, DR, Huppert, JD, Cahill, S, Vermes, D, Schmidt, AB, Hembree, E (2008). A randomized controlled trial of cognitive–behavioral therapy for augmenting pharmacotherapy in obsessive–compulsive disorder. American Journal of Psychiatry 165, 621–630.Google Scholar
Simpson, HB, Huppert, JD, Petkova, E, Foa, EB, Liebowitz, MR (2006). Response versus remission in obsessive–compulsive disorder. Journal of Clinical Psychiatry 67, 269–276.Google Scholar
Simpson, HB, Liebowitz, MR, Foa, EB, Kozak, MJ, Schmidt, AB, Rowan, V, Petkova, E, Kjernisted, K, Huppert, JD, Franklin, ME, Davies, SO, Campeas, R (2004). Post-treatment effects of exposure therapy and clomipramine in obsessive–compulsive disorder. Depression and Anxiety 19, 225–233.Google Scholar
Verbraak, MJPM, Hoogduin, CAL, Methorst, GJ, Arts, WJJM, Hansen, AMD, Keijsers, GPJ (2004). Protocollaire behandeling van patiënten met een obsessieve–compulsieve stoornis: exposure, responspreventie en cognitieve therapie (Protocolized treatment of patients with obsessive–compulsive disorder: exposure, response prevention and cognitive therapy). In Protocollaire behandelingen in de ambulante geestelijke gezondheidszorg I (Protocolized treatments in Outpatient Mental Health I) (ed. Keijsers, G. P. J., van Minnen, A. and Hoogduin, C. A. L.), pp. 63–97. Bohn Stafleu Van Loghum: Houten.Google Scholar